AJMC® in the Press, January 23, 2026
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Read More
Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma
Socioeconomic and demographic factors influenced amputation and recurrence rates in upper extremity soft tissue sarcoma.
Semaglutide Shows Promise for Steatohepatitis Resolution in MASH
Semaglutide shows promise in improving liver health and metabolic outcomes in MASH, enhancing steatohepatitis resolution and cardiometabolic measures.
Ocular Symptoms, Malignancy Common in Double Seronegative MG
A review of case studies found that patients with double seronegative myasthenia gravis (MG) had similarities in the ways their condition presented.
Suboptimal Cardiovascular Risk Management Found in Mexican Adults With Diabetes
Few adults with diabetes in Mexico achieve combined CVD risk factor control, highlighting gaps in blood pressure, cholesterol, and glycemic management.
Navigating Sexual Dysfunction in Patients With Pulmonary Fibrosis
A study shows that PF impacts sexual activity physically and emotionally, emphasizing the need for holistic patient care and quality-of-life assessments.
Assessing the Global Impact of CSU on Family and Caregivers
CSU significantly impacts family quality of life, revealing the need for comprehensive care and support for both patients and their caregivers.
Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care
The CEOs of UnitedHealth Group, CVS Health, Elevance Health, The Cigna Group, and Ascendiun attended hearings in the House of Representatives all day Thursday.
Pediatric MASH Linked to Distinct Changes in the Gut Microbiome
New research reveals gut microbiome changes in children with obesity signal liver disease progression, offering insights for early detection and intervention.
Oral Nalbuphine Significantly Reduces Chronic Cough in IPF
Oral nalbuphine significantly reduced cough frequency and severity in idiopathic pulmonary fibrosis (IPF), with patients seeing greater benefit at higher doses.
Law Enforcement Presence in EDs May Undermine Care: Prashasti Bhatnagar, Esq, MPH
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Watch
High Rates of Addiction Among Patients With Psoriasis, Other Conditions
Chronic skin diseases like psoriasis and AD are linked to high smoking and other addiction rates, highlighting the need for integrated psychosocial support.
Systemic Inflammation Linked to Disease Severity, Treatment Response in Alopecia Areata
Patients with severe alopecia areata showed significantly elevated systemic inflammatory markers compared with mild disease and healthy controls.
By Improving Sleep, TNX-102 SL Reduces Pain and Fatigue in Fibromyalgia
Sleep-focused TNX-102 SL delivered significant benefits in a phase 3 fibromyalgia study.
SGLT2 Inhibitors Linked to Lower Risk of CKD, AKI Than GLP-1 RAs
Initiating SGLT2is was linked to lower risks of chronic kidney disease and fewer acute kidney injury events than GLP-1 RAs in metformin-treated type 2 diabetes.
MRI Guideline Adherence Is Lacking in Soft Tissue Sarcoma
A single-center study found it was rare for patients with soft tissue sarcoma to have a complete set of MRI imaging.
Gates Foundation, OpenAI Launch $50M AI Health Initiative in Africa
The new Horizon1000 partnership aims to deploy AI tools across 1000 clinics to boost care, support health workers, and address aid cuts in African health systems by 2028.
Congress Unveils Massive Funding Bill to Avert Shutdown
A new bipartisan funding bill funds key departments ahead of the deadline in an effort to avoid another government shutdown.
Study Identifies 2 Distinct Epigenetic Subtypes Within Aggressive CLL
IGHV-unmutated CLL comprises 2 distinct epigenetic subtypes with different B-cell maturation signatures and genetic alterations, a study found.
Psychiatric Disorders Linked to Higher CRC Risk but Not Mortality
Patients with psychiatric disorders had higher CRC risk but no increase in CRC-specific mortality.
CKD Linked to Elevated Cardiovascular Risk Even at Early Stages
A systematic review reveals that cardiovascular risks emerge early in chronic kidney disease, highlighting the need for tailored management strategies.
Coalition's Conversation: State of the Obesity Market
Explore the evolving GLP-1 landscape with insights from industry experts, shaping future health strategies and plan designs for employers.
Corticosteroids Associated With Development of Comorbidities in Myasthenia Gravis
Minimizing the use of corticosteroids in clinical practice can help to prevent any long-term impact on patients with myasthenia gravis.
Phase 2a Trial Shows GRI-0621 Improves Biomarkers and Lung Repair in IPF
Phase 2a data show oral GRI-0621 was safe and improved immune and fibrosis biomarkers, supporting disease-modifying potential in IPF.
Precision, Access, and the Patient Journey: Navigating the Complexities of Modern Oncology
Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast cancer care and payer friction.
Medicare Facing Growing Primary Care Shortage
The decline in primary care providers threatens Medicare FFS patients' access to new visits, highlighting urgent needs for policy reform and workforce solutions.
Lipid Management Remains Central to Cardiovascular Risk Reduction in CKD
Dyslipidemia significantly impacts cardiovascular risk in chronic kidney disease, necessitating tailored lipid management strategies for optimal patient outcomes.
Inside the 24-Hour Reversal of SAMHSA Grant Cuts With NAMI's Jennifer Snow, MPA
NAMI's National Director of Government Relations and Policy, Jennifer Snow, MPA, explains how advocates rallied in support of mental health care.
Respiratory Vaccination by the Numbers: COVID-19, Flu, and RSV
The CDC reveals current vaccination trends for COVID-19, flu, and RSV during the 2025-2026 respiratory virus season, highlighting public adoption rates.
Meta-Analysis Finds No Significant NSCLC Survival Differences With ICIs, but Trial Diversity Remains Limited
This meta-analysis, which found no statistically significant OS differences by sex, age, or race with ICIs, highlights the need for more diverse, representative NSCLC trials.
